世界のGLP-1Rアゴニスト市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global GLP-1R Agonist Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4260 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、GLP-1Rアゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・GLP-1Rアゴニストの市場動向 ・企業の競争状況、市場シェア ・GLP-1Rアゴニストの種類別市場規模と予測2016-2027（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他） ・GLP-1Rアゴニストの用途別市場規模と予測2016-2027（固形腫瘍、血液関連腫瘍） ・GLP-1Rアゴニストの北米市場規模2016-2027（アメリカ、カナダ） ・GLP-1Rアゴニストの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・GLP-1Rアゴニストのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・GLP-1Rアゴニストの中南米市場規模2016-2027（メキシコ、ブラジル） ・GLP-1Rアゴニストの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Novo Nordisk、Lily、Haosoh、Sanofi、AstraZeneca） ・結論

Market Analysis and Insights: Global GLP-1R Agonist Market
The global GLP-1R Agonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GLP-1R Agonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GLP-1R Agonist market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GLP-1R Agonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GLP-1R Agonist market.

Global GLP-1R Agonist Scope and Market Size
GLP-1R Agonist market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global GLP-1R Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Exenatide
Liraglutide
Lixisenatide
Albiglutide
Others

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Novo Nordisk
Lily
Haosoh
Sanofi
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GLP-1R Agonist Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exenatide
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Others
1.3 Market by Application
1.3.1 Global GLP-1R Agonist Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global GLP-1R Agonist Market Perspective (2016-2027)
2.2 GLP-1R Agonist Growth Trends by Regions
2.2.1 GLP-1R Agonist Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 GLP-1R Agonist Historic Market Share by Regions (2016-2021)
2.2.3 GLP-1R Agonist Forecasted Market Size by Regions (2022-2027)
2.3 GLP-1R Agonist Industry Dynamic
2.3.1 GLP-1R Agonist Market Trends
2.3.2 GLP-1R Agonist Market Drivers
2.3.3 GLP-1R Agonist Market Challenges
2.3.4 GLP-1R Agonist Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top GLP-1R Agonist Players by Revenue
3.1.1 Global Top GLP-1R Agonist Players by Revenue (2016-2021)
3.1.2 Global GLP-1R Agonist Revenue Market Share by Players (2016-2021)
3.2 Global GLP-1R Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by GLP-1R Agonist Revenue
3.4 Global GLP-1R Agonist Market Concentration Ratio
3.4.1 Global GLP-1R Agonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GLP-1R Agonist Revenue in 2020
3.5 GLP-1R Agonist Key Players Head office and Area Served
3.6 Key Players GLP-1R Agonist Product Solution and Service
3.7 Date of Enter into GLP-1R Agonist Market
3.8 Mergers & Acquisitions, Expansion Plans

4 GLP-1R Agonist Breakdown Data by Type
4.1 Global GLP-1R Agonist Historic Market Size by Type (2016-2021)
4.2 Global GLP-1R Agonist Forecasted Market Size by Type (2022-2027)

5 GLP-1R Agonist Breakdown Data by Application
5.1 Global GLP-1R Agonist Historic Market Size by Application (2016-2021)
5.2 Global GLP-1R Agonist Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America GLP-1R Agonist Market Size (2016-2027)
6.2 North America GLP-1R Agonist Market Size by Type
6.2.1 North America GLP-1R Agonist Market Size by Type (2016-2021)
6.2.2 North America GLP-1R Agonist Market Size by Type (2022-2027)
6.2.3 North America GLP-1R Agonist Market Size by Type (2016-2027)
6.3 North America GLP-1R Agonist Market Size by Application
6.3.1 North America GLP-1R Agonist Market Size by Application (2016-2021)
6.3.2 North America GLP-1R Agonist Market Size by Application (2022-2027)
6.3.3 North America GLP-1R Agonist Market Size by Application (2016-2027)
6.4 North America GLP-1R Agonist Market Size by Country
6.4.1 North America GLP-1R Agonist Market Size by Country (2016-2021)
6.4.2 North America GLP-1R Agonist Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe GLP-1R Agonist Market Size (2016-2027)
7.2 Europe GLP-1R Agonist Market Size by Type
7.2.1 Europe GLP-1R Agonist Market Size by Type (2016-2021)
7.2.2 Europe GLP-1R Agonist Market Size by Type (2022-2027)
7.2.3 Europe GLP-1R Agonist Market Size by Type (2016-2027)
7.3 Europe GLP-1R Agonist Market Size by Application
7.3.1 Europe GLP-1R Agonist Market Size by Application (2016-2021)
7.3.2 Europe GLP-1R Agonist Market Size by Application (2022-2027)
7.3.3 Europe GLP-1R Agonist Market Size by Application (2016-2027)
7.4 Europe GLP-1R Agonist Market Size by Country
7.4.1 Europe GLP-1R Agonist Market Size by Country (2016-2021)
7.4.2 Europe GLP-1R Agonist Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific GLP-1R Agonist Market Size (2016-2027)
8.2 Asia-Pacific GLP-1R Agonist Market Size by Type
8.2.1 Asia-Pacific GLP-1R Agonist Market Size by Type (2016-2021)
8.2.2 Asia-Pacific GLP-1R Agonist Market Size by Type (2022-2027)
8.2.3 Asia-Pacific GLP-1R Agonist Market Size by Type (2016-2027)
8.3 Asia-Pacific GLP-1R Agonist Market Size by Application
8.3.1 Asia-Pacific GLP-1R Agonist Market Size by Application (2016-2021)
8.3.2 Asia-Pacific GLP-1R Agonist Market Size by Application (2022-2027)
8.3.3 Asia-Pacific GLP-1R Agonist Market Size by Application (2016-2027)
8.4 Asia-Pacific GLP-1R Agonist Market Size by Region
8.4.1 Asia-Pacific GLP-1R Agonist Market Size by Region (2016-2021)
8.4.2 Asia-Pacific GLP-1R Agonist Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America GLP-1R Agonist Market Size (2016-2027)
9.2 Latin America GLP-1R Agonist Market Size by Type
9.2.1 Latin America GLP-1R Agonist Market Size by Type (2016-2021)
9.2.2 Latin America GLP-1R Agonist Market Size by Type (2022-2027)
9.2.3 Latin America GLP-1R Agonist Market Size by Type (2016-2027)
9.3 Latin America GLP-1R Agonist Market Size by Application
9.3.1 Latin America GLP-1R Agonist Market Size by Application (2016-2021)
9.3.2 Latin America GLP-1R Agonist Market Size by Application (2022-2027)
9.3.3 Latin America GLP-1R Agonist Market Size by Application (2016-2027)
9.4 Latin America GLP-1R Agonist Market Size by Country
9.4.1 Latin America GLP-1R Agonist Market Size by Country (2016-2021)
9.4.2 Latin America GLP-1R Agonist Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa GLP-1R Agonist Market Size (2016-2027)
10.2 Middle East & Africa GLP-1R Agonist Market Size by Type
10.2.1 Middle East & Africa GLP-1R Agonist Market Size by Type (2016-2021)
10.2.2 Middle East & Africa GLP-1R Agonist Market Size by Type (2022-2027)
10.2.3 Middle East & Africa GLP-1R Agonist Market Size by Type (2016-2027)
10.3 Middle East & Africa GLP-1R Agonist Market Size by Application
10.3.1 Middle East & Africa GLP-1R Agonist Market Size by Application (2016-2021)
10.3.2 Middle East & Africa GLP-1R Agonist Market Size by Application (2022-2027)
10.3.3 Middle East & Africa GLP-1R Agonist Market Size by Application (2016-2027)
10.4 Middle East & Africa GLP-1R Agonist Market Size by Country
10.4.1 Middle East & Africa GLP-1R Agonist Market Size by Country (2016-2021)
10.4.2 Middle East & Africa GLP-1R Agonist Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK GLP-1R Agonist Introduction
11.1.4 GSK Revenue in GLP-1R Agonist Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk GLP-1R Agonist Introduction
11.2.4 Novo Nordisk Revenue in GLP-1R Agonist Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Lily
11.3.1 Lily Company Details
11.3.2 Lily Business Overview
11.3.3 Lily GLP-1R Agonist Introduction
11.3.4 Lily Revenue in GLP-1R Agonist Business (2016-2021)
11.3.5 Lily Recent Development
11.4 Haosoh
11.4.1 Haosoh Company Details
11.4.2 Haosoh Business Overview
11.4.3 Haosoh GLP-1R Agonist Introduction
11.4.4 Haosoh Revenue in GLP-1R Agonist Business (2016-2021)
11.4.5 Haosoh Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi GLP-1R Agonist Introduction
11.5.4 Sanofi Revenue in GLP-1R Agonist Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca GLP-1R Agonist Introduction
11.6.4 AstraZeneca Revenue in GLP-1R Agonist Business (2016-2021)
11.6.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global GLP-1R Agonist Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exenatide
Table 3. Key Players of Liraglutide
Table 4. Key Players of Lixisenatide
Table 5. Key Players of Albiglutide
Table 6. Key Players of Others
Table 7. Global GLP-1R Agonist Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global GLP-1R Agonist Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global GLP-1R Agonist Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global GLP-1R Agonist Market Share by Regions (2016-2021)
Table 11. Global GLP-1R Agonist Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global GLP-1R Agonist Market Share by Regions (2022-2027)
Table 13. GLP-1R Agonist Market Trends
Table 14. GLP-1R Agonist Market Drivers
Table 15. GLP-1R Agonist Market Challenges
Table 16. GLP-1R Agonist Market Restraints
Table 17. Global GLP-1R Agonist Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global GLP-1R Agonist Market Share by Players (2016-2021)
Table 19. Global Top GLP-1R Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP-1R Agonist as of 2020)
Table 20. Ranking of Global Top GLP-1R Agonist Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by GLP-1R Agonist Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players GLP-1R Agonist Product Solution and Service
Table 24. Date of Enter into GLP-1R Agonist Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 27. Global GLP-1R Agonist Revenue Market Share by Type (2016-2021)
Table 28. Global GLP-1R Agonist Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global GLP-1R Agonist Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global GLP-1R Agonist Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global GLP-1R Agonist Revenue Market Share by Application (2016-2021)
Table 32. Global GLP-1R Agonist Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global GLP-1R Agonist Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 35. North America GLP-1R Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America GLP-1R Agonist Market Size by Application (2016-2021) (US$ Million)
Table 37. North America GLP-1R Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America GLP-1R Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America GLP-1R Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe GLP-1R Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe GLP-1R Agonist Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe GLP-1R Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe GLP-1R Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe GLP-1R Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific GLP-1R Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific GLP-1R Agonist Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific GLP-1R Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific GLP-1R Agonist Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific GLP-1R Agonist Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America GLP-1R Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America GLP-1R Agonist Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America GLP-1R Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America GLP-1R Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America GLP-1R Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa GLP-1R Agonist Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa GLP-1R Agonist Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa GLP-1R Agonist Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa GLP-1R Agonist Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa GLP-1R Agonist Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa GLP-1R Agonist Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK GLP-1R Agonist Product
Table 67. GSK Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk GLP-1R Agonist Product
Table 72. Novo Nordisk Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Lily Company Details
Table 75. Lily Business Overview
Table 76. Lily GLP-1R Agonist Product
Table 77. Lily Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 78. Lily Recent Development
Table 79. Haosoh Company Details
Table 80. Haosoh Business Overview
Table 81. Haosoh GLP-1R Agonist Product
Table 82. Haosoh Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 83. Haosoh Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi GLP-1R Agonist Product
Table 87. Sanofi Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca GLP-1R Agonist Product
Table 92. AstraZeneca Revenue in GLP-1R Agonist Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GLP-1R Agonist Market Share by Type: 2020 VS 2027
Figure 2. Exenatide Features
Figure 3. Liraglutide Features
Figure 4. Lixisenatide Features
Figure 5. Albiglutide Features
Figure 6. Others Features
Figure 7. Global GLP-1R Agonist Market Share by Application: 2020 VS 2027
Figure 8. Solid Tumors Case Studies
Figure 9. Blood-related Tumors Case Studies
Figure 10. GLP-1R Agonist Report Years Considered
Figure 11. Global GLP-1R Agonist Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global GLP-1R Agonist Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global GLP-1R Agonist Market Share by Regions: 2020 VS 2027
Figure 14. Global GLP-1R Agonist Market Share by Regions (2022-2027)
Figure 15. Global GLP-1R Agonist Market Share by Players in 2020
Figure 16. Global Top GLP-1R Agonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP-1R Agonist as of 2020
Figure 17. The Top 10 and 5 Players Market Share by GLP-1R Agonist Revenue in 2020
Figure 18. Global GLP-1R Agonist Revenue Market Share by Type (2016-2021)
Figure 19. Global GLP-1R Agonist Revenue Market Share by Type (2022-2027)
Figure 20. North America GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America GLP-1R Agonist Market Share by Type (2016-2027)
Figure 22. North America GLP-1R Agonist Market Share by Application (2016-2027)
Figure 23. North America GLP-1R Agonist Market Share by Country (2016-2027)
Figure 24. United States GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe GLP-1R Agonist Market Share by Type (2016-2027)
Figure 28. Europe GLP-1R Agonist Market Share by Application (2016-2027)
Figure 29. Europe GLP-1R Agonist Market Share by Country (2016-2027)
Figure 30. Germany GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific GLP-1R Agonist Market Share by Type (2016-2027)
Figure 38. Asia-Pacific GLP-1R Agonist Market Share by Application (2016-2027)
Figure 39. Asia-Pacific GLP-1R Agonist Market Share by Region (2016-2027)
Figure 40. China GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America GLP-1R Agonist Market Share by Type (2016-2027)
Figure 48. Latin America GLP-1R Agonist Market Share by Application (2016-2027)
Figure 49. Latin America GLP-1R Agonist Market Share by Country (2016-2027)
Figure 50. Mexico GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa GLP-1R Agonist Market Share by Type (2016-2027)
Figure 54. Middle East & Africa GLP-1R Agonist Market Share by Application (2016-2027)
Figure 55. Middle East & Africa GLP-1R Agonist Market Share by Country (2016-2027)
Figure 56. Turkey GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE GLP-1R Agonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 61. Lily Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 62. Haosoh Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in GLP-1R Agonist Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---